These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29724031)

  • 41. Requirement for TP73 and genetic alterations originating from its intragenic super-enhancer in adult T-cell leukemia.
    Ong JZL; Yokomori R; Wong RWJ; Tan TK; Ueda R; Ishida T; Iida S; Sanda T
    Leukemia; 2022 Sep; 36(9):2293-2305. PubMed ID: 35908104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CDK7-dependent transcriptional addiction in bone and soft tissue sarcomas: Present and Future.
    Yuan J; Li X; Yu S
    Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188680. PubMed ID: 35051528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Perturbing Enhancer Activity in Cancer Therapy.
    Hamdan FH; Johnsen SA
    Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31067678
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Promiscuous targeting of bromodomains by bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia.
    Picaud S; Leonards K; Lambert JP; Dovey O; Wells C; Fedorov O; Monteiro O; Fujisawa T; Wang CY; Lingard H; Tallant C; Nikbin N; Guetzoyan L; Ingham R; Ley SV; Brennan P; Muller S; Samsonova A; Gingras AC; Schwaller J; Vassiliou G; Knapp S; Filippakopoulos P
    Sci Adv; 2016 Oct; 2(10):e1600760. PubMed ID: 27757418
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting transcription factors for cancer gene therapy.
    Libermann TA; Zerbini LF
    Curr Gene Ther; 2006 Feb; 6(1):17-33. PubMed ID: 16475943
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The ESCRT protein CHMP5 promotes T cell leukemia by controlling BRD4-p300-dependent transcription.
    Umphred-Wilson K; Ratnayake S; Tang Q; Wang R; Devaiah BN; Zhou L; Chen Q; Meerzaman D; Singer DS; Adoro S
    bioRxiv; 2024 Jan; ():. PubMed ID: 38352301
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting Super-Enhancers as a Therapeutic Strategy for Cancer Treatment.
    He Y; Long W; Liu Q
    Front Pharmacol; 2019; 10():361. PubMed ID: 31105558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Super-enhancer function and its application in cancer targeted therapy.
    Tang F; Yang Z; Tan Y; Li Y
    NPJ Precis Oncol; 2020; 4():2. PubMed ID: 32128448
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Super-enhancer in prostate cancer: transcriptional disorders and therapeutic targets.
    Chen X; Ma Q; Shang Z; Niu Y
    NPJ Precis Oncol; 2020 Nov; 4(1):31. PubMed ID: 33299103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transcription factor therapeutics: long-shot or lodestone.
    Ghosh D; Papavassiliou AG
    Curr Med Chem; 2005; 12(6):691-701. PubMed ID: 15790306
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Small molecule modulators of transcription.
    Arndt HD
    Angew Chem Int Ed Engl; 2006 Jul; 45(28):4552-60. PubMed ID: 16819755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Super-Enhancers in the Regulation of Gene Transcription: General Aspects and Antitumor Targets.
    Bruter AV; Rodionova MD; Varlamova EA; Shtil AA
    Acta Naturae; 2021; 13(1):4-15. PubMed ID: 33959383
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolic reprogramming in polycystic kidney disease explained by super-enhancers and CDK7: new therapeutic targets?
    Cassina L; Boletta A
    Nat Metab; 2020 Aug; 2(8):659-660. PubMed ID: 32694828
    [No Abstract]   [Full Text] [Related]  

  • 54. Small Molecules Co-targeting CKIα and the Transcriptional Kinases CDK7/9 Control AML in Preclinical Models.
    Minzel W; Venkatachalam A; Fink A; Hung E; Brachya G; Burstain I; Shaham M; Rivlin A; Omer I; Zinger A; Elias S; Winter E; Erdman PE; Sullivan RW; Fung L; Mercurio F; Li D; Vacca J; Kaushansky N; Shlush L; Oren M; Levine R; Pikarsky E; Snir-Alkalay I; Ben-Neriah Y
    Cell; 2018 Sep; 175(1):171-185.e25. PubMed ID: 30146162
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcriptional Silencing of MCL-1 Through Cyclin-Dependent Kinase Inhibition in Acute Myeloid Leukemia.
    Tibes R; Bogenberger JM
    Front Oncol; 2019; 9():1205. PubMed ID: 31921615
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cellular signaling and epigenetic regulation of gene expression in leukemia.
    Gowda C; Song C; Ding Y; Iyer S; Dhanyamraju PK; McGrath M; Bamme Y; Soliman M; Kane S; Payne JL; Dovat S
    Adv Biol Regul; 2020 Jan; 75():100665. PubMed ID: 31623972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic targeting of transcriptional cyclin-dependent kinases.
    Galbraith MD; Bender H; Espinosa JM
    Transcription; 2019 Apr; 10(2):118-136. PubMed ID: 30409083
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclin-dependent kinase 9 as a potential specific molecular target in NK-cell leukemia/lymphoma.
    Kinoshita S; Ishida T; Ito A; Narita T; Masaki A; Suzuki S; Yoshida T; Ri M; Kusumoto S; Komatsu H; Shimizu N; Inagaki H; Kuroda T; Scholz A; Ueda R; Sanda T; Iida S
    Haematologica; 2018 Dec; 103(12):2059-2068. PubMed ID: 30076184
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting General Transcriptional Machinery as a Therapeutic Strategy for Adult T-Cell Leukemia.
    Wong RWJ; Ishida T; Sanda T
    Molecules; 2018 May; 23(5):. PubMed ID: 29724031
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Understanding of molecular pathogenesis of T-cell leukemia by super-enhancer profiling].
    Sanda T
    Rinsho Ketsueki; 2018; 59(7):899-908. PubMed ID: 30078801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.